What is Quest Diagnostics's common stock?

Quest Diagnostics (DGX) reported common stock of $2M in Q1 2026.

How has Quest Diagnostics's common stock changed year-over-year?

Quest Diagnostics's common stock decreased by 0.0% year-over-year, from $2M to $2M.

What is the long-term trend for Quest Diagnostics's common stock?

Over 5 years (2020 to 2025), Quest Diagnostics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $2M to $2M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Quest Diagnostics DGX Common Stock

Common Stock at other companies

Myriad GeneticsMYGN

150M0.0%

Labcorp HoldingsLH

265M0.0%

Opko HealthOPK

$7.85M+11.9%

NeoGenomicsNEO

$129K+0.8%

Exagen Inc.XGN

200M0.0%

Personalis, Inc.PSNL

$10K+11.1%

Other financials

Income statement

See full

Revenue$2.9B+9.2%

Gross profit$942.0M+9.2%

Operating income$399.0M+15.3%

Net income$252.0M+14.5%

EPS (diluted)$2.24+15.5%

Balance sheet

See full

Cash & equivalents$393.0M+109%

Total debt$6.4B-2.5%

Total equity$7.4B+6.3%

Total assets$16.7B+5.5%

Cash flow

See full

Operating cash flow$278.0M-11.5%

CapEx$114.0M-2.6%

Free cash flow$164.0M-16.8%

Valuation

See full

Market cap$23.03B+18.6%

Enterprise value$29.04B+14.0%

P/E22.5×+2.0×

P/S2×+0.2×

Profitability

See full

Gross margin33.2%+0.4pp

Operating margin14.3%+0.6pp

Net margin9.1%+0.2pp

FCF margin11.8%+1.4pp

Returns & leverage

See full

Return on equity14.3%+0.9pp

Debt / equity0.9×-0.1×

Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quest Diagnostics's common stock?: Quest Diagnostics (DGX) reported common stock of $2M in Q1 2026.
How has Quest Diagnostics's common stock changed year-over-year?: Quest Diagnostics's common stock decreased by 0.0% year-over-year, from $2M to $2M.
What is the long-term trend for Quest Diagnostics's common stock?: Over 5 years (2020 to 2025), Quest Diagnostics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $2M to $2M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).